Geode Capital Management, LLC Alkermes Plc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,023,552 shares of ALKS stock, worth $112 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,023,552
Previous 3,939,694
2.13%
Holding current value
$112 Million
Previous $130 Million
11.51%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$811 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$516 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$280 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$229 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$179 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.58B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...